Author:
Fang Xin,Guo Leilei,Xing Zikang,Shi Lei,Liang Heng,Li Aiying,Kuang Chunxiang,Tao Bangbao,Yang Qing
Reference56 articles.
1. IDO in the tumor microenvironment: inflammation, counter-regulation, and tolerance;Munn;Trends Immunol.,2016
2. Pathway inhibition in cancer immunotherapy via downstream focus on the tryptophan-kynurenine-aryl hydrocarbon axis;Labadie;Clin. Cancer Res.,2019
3. Targeting the IDO1 pathway in cancer: from bench to bedside;Liu;J. Hematol. Oncol.,2018
4. The role of indoleamine-2,3-dioxygenase in cancer development, diagnostics, and therapy;Hornyák;Front. Immunol.,2018
5. IDO1 inhibition overcomes radiation-induced “rebound immune suppression” by reducing numbers of IDO1-expressing myeloid-derived suppressor cells in the tumor microenvironment;Li;Int. J. Radiat. Oncol. Biol. Phys.,2019
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献